Ce diaporama a bien été signalé.
Le téléchargement de votre SlideShare est en cours. ×

Flu vaccine case_study(slideshare)-19_jan2012

Plus De Contenu Connexe

Livres associés

Gratuit avec un essai de 30 jours de Scribd

Tout voir

Livres audio associés

Gratuit avec un essai de 30 jours de Scribd

Tout voir

Flu vaccine case_study(slideshare)-19_jan2012

  1. 1. PUBLIC POLICY CASE STUDY A review of the case study on 2004/05 U.S. Influenza Vaccine Shortage
  2. 2. The case is intended solely as a vehicle for classroom discussion Public Policy & Management class Carnegie Mellon University – Adelaide Jan 2012
  3. 3. OUTLINE An overview 1 Underlying Issues 2 Possible Solutions 3 Recommendations 4
  4. 4. Concerns raised about the fragile US vaccine situation OVERVIEW FLU:36,000 deaths 200,000 hospitalizations $11-18 billion 2004-2005, US FLU VACCINE SHORTAGE Vaccine manufacturer was suspended by England US couldn't get half of expected 100 mil doses 90mil at high risk Pricing gauging Distribution issues Government's actions: Investigation High risk areas were set priority Started to search for additional vaccine supply Imported costly flu shots High lack of vaccine supply remained Health threat remained What if this was a flu pandemic?
  5. 5. Vaccine Manufacturers CDC MHRA Media Private FDA hospitals (including) Media/ Public Relations Plan People High risk population
  6. 6. ISSUES UNDERLYING VACCINE PRODUCTION PUBLIC ADMINISTRATION SYSTEM • Production plants take time to • High FDA quality standards; set up • Poor analytical tools; • Vaccine production is time • Weak M&E system; consuming • Disconnect between public and • High-risk market private sectors; • High long-term production • Feeble intra/inter governmental costs cooperation; • Low profit margins • Poor communication FLU VACCINE CRISIS • Media frenzy; • Public health threat; • Public agitation; • Vaccine smuggling and theft; • Movement to Canada for flu vaccine shots; • Additional costs
  7. 7. CRISIS RESPONSE • CDC recommended that vaccines be reserved for high risk patients (it however lacked the authority to enforce it). • A panel to investigate the ethics of distribution was established by CDC. • A flu vaccine task force was assembled to help manage the distribution and control price. • Hospitals started sharing vaccines and doses from federal employees were diverted to high-risk civilians. • US government (Federal and State) went international to source vaccines (efforts were restrained by FDA standards and procedures). • Delayed supplies led to excess unutilized stock of vaccines.
  8. 8. POSSIBLE SOLUTIONS 1. Timely information management on public health issues. 2. Closer cooperation & alignment with other countries/international bodies (the Medicines and Healthcare Products Regulatory Agency in Britain and the US National Vaccine Advisory Committee/Federal Drug Administration). 3. Develop a more cohesive and coherent crisis management plan among the federal, state government and private agencies focused on resilience and continuity. 4. Review FDA approval/quality assurance procedures to ensure timeliness without compromising standards. 5. Develop Monitoring and Evaluation system to track problems identified as well as facilitate prompt implementation of proposed solutions. 6. Public-Private Partnerships to ensure timely production and distribution of adequate flu vaccines.
  9. 9. RECOMMENDATIONS Public-Private Partnerships to ensure timely production and distribution of adequate flu vaccines.
  10. 10. RECOMMENDATIONS Develop Monitoring and Evaluation system to track problems identified as well as facilitate prompt implementation of proposed solutions.
  11. 11. RECOMMENDATIONS Develop a more cohesive and coherent crisis management plan among the federal, state government and private agencies focused on resilience and continuity. End.
  12. 12. RECOMMENDATION SUMMARY Vaccine Public Production Administration Flu Situation Industry System Monitoring &Evaluation System Q&A ?
  13. 13. THANK YOU ! Group members: Do Thi Thien-huong Nguyen Thi Huyen Linh Oteng Karikari Chikezie Isiguzo Stephen Kihato The case is intended solely as a vehicle for classroom discussion Flu Virus: Deccanherald Images on the Newspaper page: Washington Post, AFP, Getty Images Other photos : unknown authors on Google Images, thank you.

Notes de l'éditeur

  • Hello everyone,
  • After 3 shortages of flu vaccine (2001 to 2004), production & distribution infrastructure weren't met up. Inability of American health system to ensure adequate supply of flu vaccination leading to a crisis. The case study illustrates how a chain of events, if not properly coordinated, can contributed system failure. The US government has failed to critically analyse its statistics to provide timely medical solutions to its citizens. Failure of the US flu vaccine management system Public Policy failure:Supply shortage of flu vaccination led to public outrage and media frenzy.

×